100 related articles for article (PubMed ID: 3706611)
1. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings.
Lang W; Choritz H; Hundeshagen H
Am J Surg Pathol; 1986 Apr; 10(4):246-55. PubMed ID: 3706611
[TBL] [Abstract][Full Text] [Related]
2. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma.
Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Kameyama K; Ito K
Thyroid; 2011 Jul; 21(7):751-7. PubMed ID: 21615311
[TBL] [Abstract][Full Text] [Related]
3. Follicular thyroid carcinoma: histology and prognosis.
D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
[TBL] [Abstract][Full Text] [Related]
4. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
6. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
Lukács GL; Balázs G; Zs-Nagy I; Mikó T
Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
[TBL] [Abstract][Full Text] [Related]
7. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases.
Rao RS; Parikh HK; Deshmane VH; Parikh DM; Shrikhande SS; Havaldar R
Head Neck; 1996; 18(2):118-24; discussion 124-6. PubMed ID: 8647676
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in follicular carcinoma of the thyroid.
Jorda M; Gonzalez-Campora R; Mora J; Herrero-Zapatero A; Otal C; Galera H
Arch Pathol Lab Med; 1993 Jun; 117(6):631-5. PubMed ID: 8503737
[TBL] [Abstract][Full Text] [Related]
10. [Low-risk thyroid carcinoma--therapy, follow-up and prognosis].
Sophocleous S; Ehrenheim C; Fischer J; Hundeshagen H
Nuklearmedizin; 1997 Apr; 36(3):93-102. PubMed ID: 9162908
[TBL] [Abstract][Full Text] [Related]
11. Childhood and adolescent thyroid carcinoma.
Grigsby PW; Gal-or A; Michalski JM; Doherty GM
Cancer; 2002 Aug; 95(4):724-9. PubMed ID: 12209714
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of papillary and follicular thyroid carcinoma.
Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
[TBL] [Abstract][Full Text] [Related]
13. [Small thyroid carcinomas: biological characteristics, diagnosis and therapy].
Gemsenjäger E; Schweizer I
Schweiz Med Wochenschr; 1999 May; 129(18):681-90. PubMed ID: 10407941
[TBL] [Abstract][Full Text] [Related]
14. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in patients with differentiated thyroid carcinoma.
Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
[TBL] [Abstract][Full Text] [Related]
17. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
18. Association between different variants of papillary thyroid carcinoma and risk-group according to AMES (age, metastasis, extent and size) classification system.
Keelawat S; Poumsuk U
J Med Assoc Thai; 2006 Apr; 89(4):484-9. PubMed ID: 16696394
[TBL] [Abstract][Full Text] [Related]
19. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
[TBL] [Abstract][Full Text] [Related]
20. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]